In the compelling follow-up to the internationally award-winning documentary, BURZYNSKI; BURZYNSKI: CANCER IS SERIOUS BUSINESS, PART II explores the continued journey of an innovative cancer therapy called Antineoplastons and its clinical testing sanctioned by the United States Food & Drug Administration.